GeneDx

“GeneDx is a genomics and biotechnology company that provides genetic testing, exome and genome sequencing, and clinical insights to support diagnosis, treatment decisions, and research for rare and inherited diseases. Through one of the world's largest rare disease datasets, GeneDx helps clinicians, patients, researchers, and biopharma partners advance precision medicine.”

Questions & answers

What is genetic testing?

“Genetic testing analyzes DNA to help identify genetic changes that may contribute to rare and inherited conditions. Results can help guide diagnosis, care decisions, and treatment planning for patients and families.”

How does genetic testing work?

“Genetic testing typically starts with a blood sample or cheek swab collected by a healthcare provider or through an at-home collection kit. Samples are analyzed in a laboratory, and results are reviewed by clinical experts to help guide next steps in care.”

What diseases can be detected through genetic testing?

“Genetic testing can help diagnose the genetic causes of many rare and inherited diseases and conditions, including neurodevelopmental disorders, epilepsy, movement disorders, metabolic conditions, cardiac conditions, developmental delay, intellectual disability, and other complex or unexplained symptoms. GeneDx specializes in whole exome sequencing and whole genome sequencing to help clinicians find answers for patients with suspected genetic conditions.”

Data formats & record details

Download this profile and inspect its supporting evidence.

Entity ID
urn:readyscan:entity:genedx-q5531048
Material fingerprint
fnv1a64:e419542c6bdaaab3
Entity revision
fnv1a64:5fedd1ec50b969c0
Published
2026-10-25
Modified
2026-10-25
Source summary
GeneDx: “GeneDx is a genomics and biotechnology company that provides genetic testing, exome and genome sequencing, and clinical insights to support diagnosis, treatment decisions, and research for rare and inherited diseases. Through one of the world's largest rare disease datasets, GeneDx helps clinicians, patients, researchers, and biopharma partners advance precision medicine.”
Evidence record
urn:readyscan:corpus:evidence:genedx-q5531048